Content about The New York Times

Empty shelves at Walmart are getting a lot of attention these days, but the situation isn’t new and can’t be blamed entirely on store staffing levels.

NEW YORK — More than one-tenth of school-age children and nearly one-fifth of high school boys in the United States have received a diagnosis for attention deficit hyperactivity disorder, according to published reports.

The New York Times reported that the dramatic rise in the number of children diagnosed with ADHD over the last decade could lead to concern of over-diagnosis of the condition, as well as overuse of medications to treat it. The Times based its report on an analysis of raw data from the Centers for Disease Control and Prevention.

Alabama's Supreme Court ruled in January that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports. According to the New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

NEW YORK — Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.

NEW YORK — The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

According to The New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

Beyond those in the health professions, forward-thinking healthcare advocates and pharmacists themselves, who in this country believes in the power of pharmacy to improve access to patient care, lower health costs and help Americans prevent or better manage diseases? Add the editors of the New York Times to the growing list of believers.

 NEW YORK — The impact of Hurricane Sandy has the potential of extending to holiday sales as a battered supply chain comes back online. The New York Times on Monday featured a story on those recovery efforts, noting that in addition to shutting down shipping terminals Hurricane Sandy impacted warehouses and distribution centers and slowed down delivers across the Northeast as delivery drivers contended with closed roads and gasoline shortages. 

NEW YORK — Members of Congress are calling for an inquiry into compounding pharmacies amid a meningitis outbreak that has infected 119 people and killed 11, according to published reports.

As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court’s decision to uphold the Patient Protection and Affordable Care Act, policy-makers should consider how community pharmacists can help reduce expenses. In addition, new evidence offers a fresh reminder of the perils of managed care in Medicaid and the need for proper oversight of managed care entities.

If you're an independent pharmacist trying to make ends meet in the state of Texas, good luck. A shift in the way the Lone Star State pays for Medicaid — as enacted by Texas legislature — is hammering many pharmacies, according to a June 14 report from the Texas Tribune, as reported in the New York Times.

NEW YORK — Shares of Rite Aid crossed the $2 mark Wednesday afternoon following analyst speculation about the prospects of a takeover by Walgreens, according to published reports.

DALLAS — The Department of Defense's investigation of a sports supplement ingredient — associated with the death of two soldiers — has been making headlines in the past week as the U.S. Military's independent paper Stars & Stripes ran an update of the news on Jan. 29 and the New York Times picked up on the story Feb. 2.